AC Immune SA (ACIU)
2.40
+0.06 (2.56%)
Upcoming Events
Latest Headlines
Form 4 AC Immune SA For: Jun 11 Filed by: Twyman Roy Ervin
June 15, 2026 7:10 AM - SEC Filing
Form 4 AC Immune SA For: Jun 11 Filed by: AGUIAR-LUCANDER RENEE
June 15, 2026 6:59 AM - SEC Filing
Form 4 AC Immune SA For: Jun 11 Filed by: Zuegel Martin
June 15, 2026 6:50 AM - SEC Filing
Form 4 AC Immune SA For: Jun 11 Filed by: Buetler Monika
June 15, 2026 6:40 AM - SEC Filing
Form 4 AC Immune SA For: Jun 11 Filed by: June Carl Howard
June 15, 2026 6:32 AM - SEC Filing
Form 6-K AC Immune SA For: Jun 11
June 11, 2026 4:54 PM - SEC Filing
Form 6-K AC Immune SA For: Jun 11
June 11, 2026 7:15 AM - SEC Filing
AC Immune receives $4 million grant for Parkinson's drug trial extension
June 11, 2026 7:00 AM - StreetInsider
AC Immune to Receive Research Grant from Goradia Family for Development of ACI-7104 in Parkinson’s Disease
June 11, 2026 7:00 AM - StreetInsider
AC Immune reports positive TDP-43 tracer data in ALS patients
May 22, 2026 7:00 AM - StreetInsider
AC Immune Presents New Phase 1 Data Indicating Higher Uptake of TDP-43 PET Tracer ACI-19626 in Patients with ALS
May 22, 2026 7:00 AM - StreetInsider
Form 4 AC Immune SA For: May 15 Filed by: Pfeifer Andrea
May 18, 2026 4:29 PM - SEC Filing
Form 144 AC Immune SA Filed by: Pfeifer Andrea
May 15, 2026 4:30 PM - SEC Filing
Form 6-K AC Immune SA For: May 15
May 15, 2026 9:18 AM - SEC Filing
Form 6-K AC Immune SA For: May 12
May 12, 2026 8:14 AM - SEC Filing
AC Immune CEO Dr Andrea Pfeifer to retire after 23 years
May 12, 2026 7:00 AM - StreetInsider
AC Immune Announces Retirement of CEO Dr Andrea Pfeifer at Upcoming AGM
May 12, 2026 7:00 AM - Globe NewsWire
AC Immune SA (ACIU) Reports Q1 Loss of $0.15
April 30, 2026 7:10 AM - StreetInsider
Form 6-K AC Immune SA For: Apr 30
April 30, 2026 7:09 AM - SEC Filing
Form 6-K AC Immune SA For: Apr 30
April 30, 2026 7:05 AM - SEC Filing
AC Immune First Quarter 2026 Financial and Corporate Updates
April 30, 2026 7:05 AM - Globe NewsWire
AC Immune doses first patients in final ABATE trial cohort
April 30, 2026 7:01 AM - StreetInsider
AC Immune Initiates Final Cohort in Ongoing Phase 1b/2 ABATE Trial of Anti-Abeta Active Immunotherapy to Treat Alzheimer's Disease
April 30, 2026 7:01 AM - StreetInsider
AC Immune starts final cohort in alzheimer's drug trial
April 30, 2026 7:01 AM - StreetInsider
AC Immune Initiates Final Cohort in Ongoing Phase 1b/2 ABATE Trial of Anti-Abeta Active Immunotherapy to Treat Alzheimer's Disease
April 30, 2026 7:00 AM - Globe NewsWire
Form 4/A AC Immune SA For: Apr 15 Filed by: Pfeifer Andrea
April 16, 2026 12:39 PM - SEC Filing
Form 4 AC Immune SA For: Apr 15 Filed by: Pfeifer Andrea
April 16, 2026 11:11 AM - SEC Filing
Form 144 AC Immune SA Filed by: Pfeifer Andrea
April 15, 2026 4:52 PM - SEC Filing
Leerink Partners on AC Immune SA (ACIU): Lilly deal amendment is 'great news,' validates platform
April 7, 2026 2:44 PM - StreetInsider
Form 6-K AC Immune SA For: Apr 02
April 7, 2026 12:46 PM - SEC Filing
AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly
April 7, 2026 9:41 AM - Globe NewsWire
AC Immune amends Lilly collaboration for tau drug development
April 7, 2026 7:01 AM - StreetInsider
AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly
April 7, 2026 7:00 AM - StreetInsider
Form 3 AC Immune SA For: Mar 18 Filed by: Zuegel Martin
April 1, 2026 4:51 PM - SEC Filing
Full Article List
